|
SCAI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.021800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.415800E-02 |
| Normal-vs-Stage2 |
6.023200E-04 |
| Normal-vs-Stage3 |
4.215400E-03 |
| Normal-vs-Stage4 |
9.003900E-04 |
| Stage1-vs-Stage2 |
2.260000E-02 |
| Stage1-vs-Stage3 |
1.113550E-01 |
| Stage1-vs-Stage4 |
3.198400E-02 |
| Stage2-vs-Stage3 |
2.564000E-01 |
| Stage2-vs-Stage4 |
8.591000E-01 |
| Stage3-vs-Stage4 |
3.367000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.419700E-03 |
| Normal-vs-AfricanAmerican |
4.950200E-01 |
| Normal-vs-Asian |
1.504820E-01 |
| Caucasian-vs-AfricanAmerican |
2.947200E-01 |
| Caucasian-vs-Asian |
4.128200E-01 |
| AfricanAmerican-vs-Asian |
6.992400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.257700E-02 |
| Normal-vs-Female |
1.022080E-02 |
| Male-vs-Female |
7.919400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.978170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.077540E-02 |
| Normal-vs-Age(61-80Yrs) |
9.571100E-04 |
| Normal-vs-Age(81-100Yrs) |
6.916300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.295500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.957100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.218300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.998600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.361160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.206000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.438600E-01 |
| Classical-VS-Follicular |
1.646980E-04 |
| Classical-VS-Other |
4.455000E-01 |
| Classical-VS-Normal |
7.764000E-02 |
| Tall-VS-Follicular |
2.217600E-01 |
| Tall-VS-Other |
3.361800E-01 |
| Tall-VS-Normal |
2.902000E-02 |
| Follicular-VS-Other |
2.352400E-01 |
| Follicular-VS-Normal |
5.97999999999432E-05 |
| Other-VS-Normal |
6.241200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.997300E-03 |
| Normal-vs-N1 |
3.853700E-02 |
| N0-vs-N1 |
7.384800E-01 |
|
|
